Mr Richard Chun-hsien Chu, DO | |
4631 S Hulen St, Fort Worth, TX 76132-1401 | |
(817) 346-7077 | |
(817) 346-6998 |
Full Name | Mr Richard Chun-hsien Chu |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Experience | 13 Years |
Location | 4631 S Hulen St, Fort Worth, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164728044 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 5101017963 (Michigan) | Secondary |
174400000X | Specialist | P3302 (Texas) | Primary |
Entity Name | Chu Eye Institute, P.a. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740537281 PECOS PAC ID: 3072762707 Enrollment ID: O20121012000320 |
News Archive
Eleven researchers from the University of Amsterdam (UvA) have been named as recipients of Starting Independent Researcher Grants from the European Research Council.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
The first ever review of abuse cases related to child death or serious injury in Northern Ireland will be launched at Queen's University today (24 January 2013). The review, Translating Learning into Action, was commissioned by the Department of Health, Social Services and Public Safety (DHSSPS) and was carried out by researchers at Queen's University and the NSPCC.
Duchenne muscular dystrophy (DMD), a progressive muscle disease affecting one in 3800-6300 live male births and leads to ambulatory loss, respiratory problems, cardiomyopathy, and early death of patients in their 20s or 30s.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Richard Chun-hsien Chu, DO 4631 S Hulen St, Fort Worth, TX 76132-1401 Ph: (817) 346-7077 | Mr Richard Chun-hsien Chu, DO 4631 S Hulen St, Fort Worth, TX 76132-1401 Ph: (817) 346-7077 |
News Archive
Eleven researchers from the University of Amsterdam (UvA) have been named as recipients of Starting Independent Researcher Grants from the European Research Council.
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced initiation of dosing of patients in a major Phase II/III clinical trial of plecanatide to treat chronic idiopathic constipation.
The first ever review of abuse cases related to child death or serious injury in Northern Ireland will be launched at Queen's University today (24 January 2013). The review, Translating Learning into Action, was commissioned by the Department of Health, Social Services and Public Safety (DHSSPS) and was carried out by researchers at Queen's University and the NSPCC.
Duchenne muscular dystrophy (DMD), a progressive muscle disease affecting one in 3800-6300 live male births and leads to ambulatory loss, respiratory problems, cardiomyopathy, and early death of patients in their 20s or 30s.
› Verified 3 days ago